SYSTEMS AND METHODS FOR ALTERNATE MODES IN AUTOMATED INSULIN DELIVERY FOR DIABETES THERAPY
Disclosed herein are systems and methods for automated insulin delivery that provide an Alternate Normal Activity Mode that has a lower and narrower target range than the standard range employed in Normal Mode. The Alternative Normal Mode can be a user-selectable feature that provides more aggressive glucose level control that is designed to decrease hyperglycemia without significantly increasing the risk of hypoglycemia. For example, Normal Mode may employ a standard glucose range between which the closed loop algorithm attempts to maintain the user's glucose levels such as 112.5 mg/dL to 160 mg/dL and Alternative Normal Mode may employ a lower and narrower range such as 90 mg/dL to 130 mg/dL. Alternative Normal Mode can also employ a lockout feature that is activated when glucose is high, but is falling rapidly.
1 . An ambulatory infusion pump system, comprising:
a pump mechanism configured to facilitate delivery of insulin to a user;
a user interface;
a communications interface adapted to receive glucose levels from a continuous glucose monitor; and
at least one processor configured to:
present on the user interface at least two options for calculating and delivering insulin doses according to a closed loop delivery algorithm during normal activity of the user, including a normal activity mode having a first glucose range between which the closed loop delivery algorithm attempts to maintain the user's glucose levels and an alternate normal activity mode having a second glucose range;
receive input through the user interface selecting the alternative normal activity mode;
automatically calculate insulin doses with a closed loop delivery algorithm based on glucose levels received from the continuous glucose monitor according to the selected option;
automatically deliver the insulin doses calculated by the closed loop delivery algorithm to the user with the pump mechanism; and
selectively prevent delivery of automatic correction boluses that would otherwise be delivered due to the user's glucose level being over a high threshold in the alternate normal activity mode with a bolus lockout feature.
2 . The ambulatory infusion pump system of claim 1 , wherein the second glucose range is lower and narrower than the first glucose range.
3 . The ambulatory infusion pump system of claim 2 , wherein both a low glucose level and a high glucose level of the second glucose range are lower than a corresponding low glucose level and high glucose level of the first glucose range.
4 . The ambulatory infusion pump system of claim 1 , wherein the at least one processor is further configured to automatically suspend insulin delivery if the user's glucose level is below a low glucose threshold.
5 . The ambulatory infusion pump system of claim 4 , wherein the low glucose threshold is below both the first glucose range and the second glucose range.
6 . The ambulatory infusion pump system of claim 4 , wherein the low glucose threshold is equal to a low glucose level of the second glucose range.
7 . The ambulatory infusion pump system of claim 1 , wherein the at least one processor is configured prevent delivery of automatic correction boluses that would otherwise be delivered due to the user's glucose level being over a high threshold in the alternate normal activity mode with the bolus lockout feature when delivery of an automatic correction bolus would cause a risk of a low glucose level in the user.
8 . The ambulatory infusion pump system of claim 7 , wherein the at least one processor is configured to determine that delivery of an automatic correction bolus would cause a risk of a low glucose level if a rate of change of the user's glucose levels is falling at more than a predetermined rate.
9 . The ambulatory infusion pump system of claim 7 , wherein the at least one processor is configured to determine that delivery of an automatic correction bolus would cause a risk of a low glucose level in the user if a current glucose level of the user is greater than a predicted future glucose level of the user.
10 . The ambulatory infusion pump system of claim 7 , wherein the at least one processor is configured to determine that delivery of an automatic correction bolus would cause a risk of a low glucose level in the user if a low glucose alert indicating that a glucose level of a user is below a low threshold had been issued within a predetermined period of time.
11 . An ambulatory infusion pump system, comprising:
a pump mechanism configured to facilitate delivery of insulin to a user;
a user interface;
a communications interface adapted to receive glucose levels from a continuous glucose monitor; and
at least one processor configured to:
present on the user interface at least two options for calculating and delivering insulin doses according to a closed loop delivery algorithm during normal activity of the user, including a normal activity mode having a first glucose range between which the closed loop delivery algorithm attempts to maintain the user's glucose levels and an alternate normal activity mode having a second glucose range that is lower and narrower than the first glucose range;
receive input through the user interface selecting the alternative normal activity mode;
automatically calculate insulin doses with a closed loop delivery algorithm based on glucose levels received from the continuous glucose monitor according to the selected option; and
automatically deliver the insulin doses calculated by the closed loop delivery algorithm to the user with the pump mechanism.
12 . The ambulatory infusion pump of claim 11 , wherein the at least one processor is configured to selectively prevent delivery of automatic correction boluses that would otherwise be delivered due to the user's glucose level being over a high threshold in the alternate normal activity mode with a bolus lockout feature.
13 . The ambulatory infusion pump system of claim 12 , wherein the at least one processor is configured prevent delivery of automatic correction boluses that would otherwise be delivered due to the user's glucose level being over a high threshold in the alternate normal activity mode with the bolus lockout feature when delivery of an automatic correction bolus would cause a risk of a low glucose level in the user.
14 . The ambulatory infusion pump system of claim 13 , wherein the at least one processor is configured to determine that delivery of an automatic correction bolus would cause a risk of a low glucose level if a rate of change of the user's glucose levels is falling at more than a predetermined rate.
15 . The ambulatory infusion pump system of claim 14 , wherein the at least one processor is configured to determine that delivery of an automatic correction bolus would cause a risk of a low glucose level in the user if a current glucose level of the user is greater than a predicted future glucose level of the user.
16 . The ambulatory infusion pump system of claim 13 , wherein the at least one processor is configured to determine that delivery of an automatic correction bolus would cause a risk of a low glucose level in the user if a low glucose alert indicating that a glucose level of a user is below a low threshold had been issued within a predetermined period of time.
17 . The ambulatory infusion pump system of claim 11 , wherein both a low glucose level and a high glucose level of the second glucose range are lower than a corresponding low glucose level and high glucose level of the first glucose range.
18 . The ambulatory infusion pump system of claim 11 , wherein the at least one processor is further configured to automatically suspend insulin delivery if the user's glucose level is below a low glucose threshold.
19 . The ambulatory infusion pump system of claim 18 , wherein the low glucose threshold is below both the first glucose range and the second glucose range.
20 . The ambulatory infusion pump system of claim 18 , wherein the low glucose threshold is equal to a low glucose level of the second glucose range.